[1] Article Title: A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort
	•	Line(s): 193
	•	Section: Title Page
	•	Quote(s): “A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort”

⸻

[2] Publication Year: 2022
	•	Line(s): 193
	•	Section: Journal Header
	•	Quote(s): “Journal of Neuromuscular Diseases 9 (2022) 193–210”

⸻

[3] Region: Middle East
	•	Line(s): 194
	•	Section: Introduction
	•	Quote(s): “especially in the Middle East, where the prevalence of these diseases is thought to be high and underestimated”

⸻

[4] Country: Lebanon
	•	Line(s): 194
	•	Section: Abstract
	•	Quote(s): “This study aims to provide a retrospective overview of hereditary NMDs based on our clinical consultations in Lebanon.”

⸻

[5] Coverage Area: National
	•	Line(s): 194, 195
	•	Section: Methods
	•	Quote(s): “Patients were mainly referred… from various Lebanese hospitals and clinics.”

⸻

[6] Study Design: Retrospective cohort study
	•	Line(s): 194, 195
	•	Section: Abstract, Methods
	•	Quote(s): “retrospective overview… over a 20-year period (1999–2019)”
“Clinical and genetic reports… compiled from available medical records.”

⸻

[7] Study Population: Patients referred for neuromuscular disorders
	•	Line(s): 195
	•	Section: Methods
	•	Quote(s): “Patients were mainly referred by neuropediatricians, adult neurologists, pathologists, and orthopedic surgeons…”

⸻

[8] Population Characteristics: 506 patients; 57.5% male, 42.5% female; age 0–60 years; pediatric predominant
	•	Line(s): 196
	•	Section: Results
	•	Quote(s): “506 patients, including 291 males (57.5%) and 215 females (42.5%)… diagnosed between the ages of 0 and 60… pediatric disease presentation (median = 2yrs; mean = 8yrs).”

⸻

[9] Data Source Type: Clinical data and genetic lab data
	•	Line(s): 195
	•	Section: Methods
	•	Quote(s): “Clinical and genetic reports of patients… compiled from available medical records.”
“Genetic testing was carried out in different Lebanese private laboratories… as well as in public or private laboratories abroad”

⸻

[10] Data Source Details: Clinical referrals from hospitals; testing by local and international genetic labs
	•	Line(s): 195
	•	Section: Methods
	•	Quote(s): “Patients were mainly referred by… from various Lebanese hospitals and clinics.”
“Genetic testing was carried out in different Lebanese private laboratories… abroad, whenever the required test was not available in Lebanon.”

⸻

[11] Study Timeline Type: Retrospective
	•	Line(s): 194
	•	Section: Abstract
	•	Quote(s): “This study aims to provide a retrospective overview…”

⸻

[12] Number of Sites: Multiple (across Lebanese hospitals and clinics)
	•	Line(s): 195
	•	Section: Methods
	•	Quote(s): “Patients were mainly referred… from various Lebanese hospitals and clinics.”

⸻

[13] Study Start Year: 1999
	•	Line(s): 194
	•	Section: Abstract
	•	Quote(s): “over a 20-year period (1999–2019)”

⸻

[14] Study End Year: 2019
	•	Line(s): 194
	•	Section: Abstract
	•	Quote(s): “over a 20-year period (1999–2019)”

⸻

[15] Main Ethnicity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[16] Ethnicity Details: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[17] Disease Studied: Neuromuscular disorders (NMDs), including subtypes like SMA, DMD, BMD, LGMD, CMT
	•	Line(s): 194, 196
	•	Section: Abstract, Results
	•	Quote(s): “62 different disorders encompassing 10 classes of NMDs… spinal muscular atrophy (SMA)… Duchenne and Becker muscular dystrophy…”

⸻

[18] Diagnosis Method: Clinical and molecular (e.g., sequencing, PCR, MLPA)
	•	Line(s): 195
	•	Section: Methods
	•	Quote(s): “confirmed only clinically or coupled with molecular diagnosis… Multiplex PCR, Southern blot, MLPA, Sanger sequencing… Next Generation Sequencing (NGS)… Whole Exome Sequencing (WES)”

⸻

[19] Diagnosis Criteria Details: Clinical phenotype and genetic confirmation per ACMG guidelines
	•	Line(s): 195
	•	Section: Methods
	•	Quote(s): “All patients underwent thorough clinical and medical investigations… categorized based on the guidelines of the American College of Medical Genetics and Genomics (ACMG).”

⸻

[20] Disease Phase: NR (mixed acute and chronic implied)
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[21] Cohort Age Group: Mixed (predominantly pediatric)
	•	Line(s): 196
	•	Section: Results
	•	Quote(s): “diagnosed between the ages of 0 and 60, and mainly exhibited a pediatric disease presentation”

⸻

[22] Female % in Cohort: 42.5%
	•	Line(s): 196
	•	Section: Results
	•	Quote(s): “including 291 males (57.5%) and 215 females (42.5%)”

⸻

[23] Consanguinity: Not directly reported; population has high consanguinity (28.4–35.5%)
	•	Line(s): 205
	•	Section: Limitations
	•	Quote(s): “we do not report on parental consanguinity… this may be attributed to high rates of consanguinity, estimated to be an average between 28.4% and 35.5% in Lebanon”